Life Science Company News

Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Essity decides to buy back shares for SEK 3bn

Read more ››
By: PR Newswire Association LLC. - 17 Jun 2024

ZINZINO AB (PUBL): LETTER OF INTENT TO ACQUIRE ZURVITA INCREASES DISTRIBUTION POWER IN NORTH AMERICA

Read more ››
By: PR Newswire Association LLC. - 17 Jun 2024

MGI Tech and SeqOne Partner to Advance End-to-end Genomic Analysis

Read more ››
By: PR Newswire Association LLC. - 17 Jun 2024

ACQUISITION OF ARGATROBAN BUSINESS IN EUROPE

Read more ››
By: PR Newswire Association LLC. - 17 Jun 2024

Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients

Read more ››
By: PR Newswire Association LLC. - 17 Jun 2024

Funding secured for CE approval of the groundbreaking C-MIC device from Berlin Heals Holding AG

Read more ››
By: PR Newswire Association LLC. - 17 Jun 2024

argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024

Read more ››
By: GlobeNewswire - 17 Jun 2024

ISTH 2024 Unveils Late-Breakthrough Abstracts to be Presented in Bangkok, Thailand Showcasing Groundbreaking Science and Research

Read more ››
By: PR Newswire Association LLC. - 17 Jun 2024

HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology

Read more ››
By: GlobeNewswire - 17 Jun 2024

Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma

Read more ››
By: GlobeNewswire - 16 Jun 2024

Crisis Prevention Institute Launches New Neuroscience-based Training for Educators

Read more ››
By: PR Newswire Association LLC. - 16 Jun 2024

Berberine Could Treat Eczema-Exacerbated Staphylococcus aureus Infections

Read more ››
By: PR Newswire Association LLC. - 16 Jun 2024

More than 2400 Canadians took to the streets of Toronto to raise an unprecedented $1.63 million for life-saving cancer research and clinical care at The Princess Margaret

Read more ››
By: PR Newswire Association LLC. - 16 Jun 2024

Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)

Read more ››
By: GlobeNewswire - 16 Jun 2024

Biotech entrepreneur donates $50 million to UC Irvine School of Biological Sciences

Read more ››
By: PR Newswire Association LLC. - 16 Jun 2024

Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress

Read more ››
By: GlobeNewswire - 15 Jun 2024

Roche’s Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma

Read more ››
By: GlobeNewswire - 15 Jun 2024

CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024

Read more ››
By: PR Newswire Association LLC. - 15 Jun 2024

IASO Bio Presented New Data of FUCASO® (Equecabtagene Autoleucel) for the Treatment of High-risk Newly Diagnosed Multiple Myeloma in Oral Presentation at EHA 2024

Read more ››
By: PR Newswire Association LLC. - 15 Jun 2024

Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase 2 study

Read more ››
By: PR Newswire Association LLC. - 15 Jun 2024
Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate